At the 69th Annual Meeting of the Society for Thrombosis and Haemostasis Research (GTH), which took place in Lausanne from February 18 to 21, 2025, the Young Investigator Award for Bleeding Diseases was presented to Dr. Cornelia Englisch, member of the Thrombosis and Haemostasis Research Group of the Clinical Division of Haematology and Haemostaseology. The award-winning paper entitled “Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study” was published in the journal Blood 2024 (doi:10.1182/blood.2024025362).
Dr. Cornelia Englisch is working on coagulation disorders in cancer patients as part of her PhD studies. The award-winning study looked at the risk of bleeding in cancer patients and was able to show that the risk of bleeding is very high in a cancer population from everyday clinical practice. This high risk was also demonstrated in patients who did not receive anticoagulation. In particular, patients with tumors in the head and neck area, low albumin and hemoglobin levels (both routine laboratory parameters) showed a particularly high risk of bleeding. It was also found that some bleeding events were life-threatening, which was the case in a total of 10 % of all severe bleeding events observed.